Full Text
Economic impact of dapagliflozin vs. Other antidiabetic drugs for the treatment of patients with type 2 diabetes

Abstract

Authors

J. Lin P. Dhankhar K. Bell J. Chhatwal M. Lingohr-Smith

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×